167
Participants
Start Date
August 22, 2018
Primary Completion Date
April 6, 2020
Study Completion Date
April 6, 2020
ARGX-113
Intravenous administration of ARGX-113
Placebo
Intravenous administration of placebo
Investigator Site 55, Budapest
Investigator Site 15, Copenhagen
Investigator Site 11, Edegem
Investigator Site 54, Szeged
Investigator Site 36, Aarhus
Investigator Site 8, Ghent
Investigator Site 33, Berlin
Investigator Site 61, Belgrade
Investigator Site 52, Marseille
Investigator Site 53, Buffalo
Investigator Site 10, Milan
Investigator Site 2, Charlottesville
Investigator Site 3, Chapel Hill
Investigator Site 17, Charleston
Investigator Site 34, Jacksonville
Investigator Site 13, Bordeaux
Investigator Site 4, Tampa
Investigator Site, Cordova
Investigator Site 20, Cleveland
Investigator Site 48, Detroit
Investigator Site 25, Iowa City
Investigator Site 32, Brno
Investigator Site 30, Springfield
Investigator Site 21, Kansas City
Investigator Site 35, Ostrava-Poruba
Investigator Site 44, Houston
Investigator Site 6, San Antonio
Investigator Site 58, Aurora
Investigator Site 12, Napoli
Investigator Site 29, Phoenix
Investigator Site 5, Los Angeles
Investigator Site 49, Los Angeles
Investigator Site 66, Carlsbad
Investigator Site 18, Orange
Investigator Site 59, San Francisco
Investigator Site 40, Palo Alto
Investigator Site 9, Portland
Investigator Site 16, Seattle
Investigator Site 60, Samara
Investigator Site 62, Nizhny Novgorod
Investigator Site 65, Novosibirsk
Investigator Site 64, Krasnoyarsk
Investigator Site 31, Meguro City
Investigator Site 28, Ōsaka-sayama
Investigator Site 27, Boston
Investigator Site 38, Edmonton
Investigator Site 24, Toronto
Investigator Site 22, Montreal
Investigator Site 51, Prague
Investigator Site 46, Tbilisi
Investigator Site 45, Tbilisi
Investigator Site 47, Tbilisi
Investigator Site 42, Chiba
Investigator Site 26, Sapporo
Investigator Site 19, Hanamaki
Investigator Site 43, Sendai
Investigator Site 50, Suita
Investigator Site 41, Minato-Ku
Investigator Site 39, Shinjuku-Ku
Investigator Site 37, Leiden
Investigator Site 7, Gdansk
Investigator Site 57, Katowice
Investigator Site 14, Krakow
Investigator Site 23, Warsaw
Investigator Site 63, Edgbaston
Investigator Site 56, Liverpool
Lead Sponsor
argenx
INDUSTRY